Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. (Nasdaq: AMHC) is a clinical-stage biopharmaceutical company that emerged from a business combination with Amplitude Healthcare Acquisition Corporation, a blank-check vehicle sponsored by Amplitude Healthcare Sponsor, LLC that completed its initial public offering in 2021. Operating in the healthcare and biotechnology sector, the company focuses on hematopoietic stem cell transplantation therapies and filed an 8-K current report with the SEC on May 14, 2026. As a post-merger public company, Jasper Therapeutics continues developing treatments aimed at making stem cell transplants safer and more broadly accessible to patients. Sign up for full data on SpacDesk to access complete filing histories, sponsor profiles, and SPAC analytics for AMHC and hundreds of other transactions.